Capecitabine
Carbamic acid, [1-(5-deoxy--d-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-, pentyl ester. Pentyl 1-(5-deoxy--d-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate [154361-50-9]. » Capecitabine contains not less than 98.0 percent and not more than 102.0 percent of C15H22FN3O6, calculated on the anhydrous and solvent-free basis.
Packaging and storage
Preserve in tight containers. Store at controlled room temperature.
USP Reference standards 11
USP Capecitabine RS . USP Capecitabine Related Compound A RS . USP Capecitabine Related Compound B RS . USP Capecitabine Related Compound C RS .
Identification
B:
The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Water, Method Ic 921:
not more than 0.3%.
Specific rotation 781S:
between +96.0 and +100.0.
Test solution:
10 mg per mL, on the anhydrous and solvent-free basis, in methanol, at 20.
Residue on ignition 281:
not more than 0.1%.
Heavy metals, Method II 231:
not more than 20 ppm.
Related compounds
Diluent, Solution A, Solution B, Peak identification solution, and Chromatographic system
Proceed as directed in the Assay.
Standard solution
Use the Standard preparation, prepared as directed in the Assay.
Test solution
Use the Assay preparation, prepared as directed in the Assay.
Procedure
Separately inject equal volumes (about 10 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the peak responses. Calculate the percentage of each impurity in the portion of Capecitabine taken by the formula:
100(1/F)(CS / CU)(rI / rS)
in which F is the relative response factor for each impurity obtained from Table 1; CS is the concentration, in mg per mL, of USP Capecitabine RS in the Standard solution; CU is the concentration, in mg per mL, of capecitabine in the Test solution; rI is the peak response for each impurity obtained from the Test solution; and rS is the peak response for capecitabine obtained from the Standard solution. The limits are given in Table 1.
Table 1
Assay
Diluent
Prepare a mixture of water, methanol, and acetonitrile (60:35:5).
Diluted acetic acid
Prepare a 0.1% (v/v) mixture of acetic acid in water.
Solution A
Prepare a mixture of Diluted acetic acid, methanol, and acetonitrile (60:35:5).
Solution B
Prepare a mixture of methanol, Diluted acetic acid, and acetonitrile (80:15:5).
Standard preparation
Dissolve an accurately weighed quantity of USP Capecitabine RS in Diluent, and sonicate if necessary, to obtain a solution having a known concentration of about 0.6 mg per mL.
Peak identification solution
Dissolve suitable quantities of USP Capecitabine RS, USP Capecitabine Related Compound A RS, USP Capecitabine Related Compound B RS, and USP Capecitabine Related Compound C RS in Diluent, and sonicate if necessary, to obtain a solution having known concentrations of about 0.06 mg of each per mL. Quantitatively dilute this solution with Diluent to obtain a solution having known concentrations of about 0.6 µg of each per mL.
Assay preparation
Dissolve an accurately weighed quantity of Capecitabine in Diluent, and sonicate if necessary, to obtain a solution having a known concentration of about 0.6 mg per mL.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 250-nm detector, a refrigerated autosampler at 5, and a 4.6-mm × 25-cm column that contains 5-µm packing L1. The flow rate is about 1 mL per minute. The column temperature is maintained at 40. The chromatograph is programmed as follows.
Procedure
Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the capecitabine peaks. Calculate the quantity, in percentage, of C15H22FN3O6 in the portion of Capecitabine taken by the formula:
100(CS / CU)(rU / rS)
in which CS is the concentration, in mg per mL, of USP Capecitabine RS in the Standard preparation; CU is the concentration, in mg per mL, of capecitabine in the Assay preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
Chromatographic Column
USP32NF27 Page 1774
Pharmacopeial Forum: Volume No. 32(4) Page 1052
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|